Generic and Biosimilar Cancer Medicines
Estimated value
—
Awarded value
—
Suppliers
67
Lots
33
Published
21 Apr 2023
Total lots
33
Awarded
33
Estimated total
£56.5m
Awarded total
—
Lot 1 Bendamustine Powder For Solution For Infusion
Start
—
End
—
Estimated
£95k
CPV
Lot 2 Capecitabine Tablets
Start
—
End
—
Estimated
£911k
CPV
Lot 3 Carboplatin Injection
Start
—
End
—
Estimated
£597k
CPV
Lot 4 Cisplatin Injection
Start
—
End
—
Estimated
£186k
CPV
Lot 5 Cyclophosphamide Injection, Powder For Reconstitution
Start
—
End
—
Estimated
£267k
CPV
Lot 6 Cytarabine Injections
Start
—
End
—
Estimated
£105k
CPV
Lot 7 Dacarbazine Injections
Start
—
End
—
Estimated
£593k
CPV
Lot 8 Disodium Folinate Injection
Start
—
End
—
Estimated
£442k
CPV
Lot 9 Docetaxel Concentrate For Solution For Infusion
Start
—
End
—
Estimated
£333k
CPV
Lot 10 Doxorubicin Hydrochloride Injections
Start
—
End
—
Estimated
£60k
CPV
Lot 12 Fluorouracil 50MG/ML Injection
Start
—
End
—
Estimated
£236k
CPV
Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials
Start
—
End
—
Estimated
£109k
CPV
Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials
Start
—
End
—
Estimated
£18k
CPV
Lot 17 Ifosfamide Injection Powder For Reconstitution
Start
—
End
—
Estimated
£2.7m
CPV
Lot 18 Irinotecan Hydrochloride Injection
Start
—
End
—
Estimated
£248k
CPV
Lot 19 Lanreotide Injection Prefilled Syringes
Start
—
End
—
Estimated
£4.7m
CPV
Lot 20 Methotrexate Without Preservatives Injection
Start
—
End
—
Estimated
£305k
CPV
Lot 21 Methotrexate Oral Solution
Start
—
End
—
Estimated
£56k
CPV
Lot 23 Oxaliplatin Vial Solution
Start
—
End
—
Estimated
£209k
CPV
Lot 24 Paclitaxel Concentrate For Intravenous Infusion
Start
—
End
—
Estimated
£407k
CPV
Lot 25 Temozolomide Capsules
Start
—
End
—
Estimated
£146k
CPV
Lot 26 Vincristine Without Preservatives Injection
Start
—
End
—
Estimated
£71k
CPV
Lot 27 Vinorelbine Injection
Start
—
End
—
Estimated
£54k
CPV
Lot 28 Aprepitant Capsules
Start
—
End
—
Estimated
£116k
CPV
Lot 31 Octreotide Injection
Start
—
End
—
Estimated
£167k
CPV
Lot 32 Filgrastim Pre-Filled Syringe
Start
—
End
—
Estimated
£1.6m
CPV
Lot 33 Pemetrexed Powder For Solution For Infusion Vials
Start
—
End
—
Estimated
£198k
CPV
Lot 34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials
Start
—
End
—
Estimated
£212k
CPV
Lot 38 Dasatinib Tablets
Start
—
End
—
Estimated
£143k
CPV
Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
Start
—
End
—
Estimated
£10.5m
CPV
Lot 37 Etoposide Injection
Start
—
End
—
Estimated
£168k
CPV
Lot 40 Idarubicin Hydrochloride Solution for Infusion
Start
—
End
—
Estimated
£13k
CPV
Lot 41 Single Supplier Generic Medicines
Start
—
End
—
Estimated
£30.4m
CPV